Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Zoetis (Group)

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. *

 

Period Start 2016-11-15 existent
Products Industry animal health
  Industry 2 veterinary diagnostics
     
  City n. a. 
    Address record changed: 2023-07-07
     
Basic data Employees H: 10,001 to 50,00 (2022-12-31)
  Currency USD
  Annual sales 8,100,000,000 (revenue, annual, consolidated (2022) 2022-12-31)
     
    * Document for »About Section«: Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides".
     
   
Record changed: 2023-07-07

Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Zoetis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top